Cytoplasmic PELP1 and ERRgamma Protect Human Mammary Epithelial Cells from Tam-Induced Cell Death

Tamoxifen (Tam) is the only FDA-approved chemoprevention agent for pre-menopausal women at high risk for developing breast cancer. While Tam reduces a woman's risk of developing estrogen receptor positive (ER+) breast cancer, the molecular mechanisms associated with risk reduction are poorly un...

Descripción completa

Detalles Bibliográficos
Autores principales: Girard, Brian J., Regan Anderson, Tarah M., Welch, Siya Lem, Nicely, Julie, Seewaldt, Victoria L., Ostrander, Julie H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366195/
https://www.ncbi.nlm.nih.gov/pubmed/25789479
http://dx.doi.org/10.1371/journal.pone.0121206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366195/
https://www.ncbi.nlm.nih.gov/pubmed/25789479
http://dx.doi.org/10.1371/journal.pone.0121206

Ejemplares similares